Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Dr Kimia Ziahosseini and colleagues from the Royal Liverpool University Hospital and Manchester Royal Eye Hospital describe the case of a teenager who presented with central scotomas (dark spots) after he bought a green diode laser pointer over the Internet and shone the laser beam into his eyes while playing with it.
His visual acuity was poor and tests revealed burns to the surface of the eye and disturbances to the retina, the light-sensitive tissue at the back of the eye. Two months later, his visual acuity improved but some retinal damage remained.
The authors warn that, although lasers may cause only a transient afterimage, they can lead to permanent retinal damage and visual loss in later years.
The U.K. Health Protection Agency has received no previous reports of such injury from laser pointers, they write. It advises that laser products sold to the general public for use as laser pointers should be restricted to devices with laser power less than 1 mW, in accordance with the British Standard, and be accompanied by sufficient information on their safe operation.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.